Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Study Links Systemic Sclerosis to Higher Cancer Risk
October 2025
Study links systemic sclerosis to elevated cancer risks, varying by specific autoantibody profiles.
Read more
22 Jul 2025
ICML 2025: Blood Test Shows Promise for Tracking Lymphoma Relapse Risk
Real-world data presented at the 2025 International Conference on Malignant Lymphoma (ICML) has provided new insights into the use of clonoSEQ, a circulating tumour DNA (ctDNA) assay…
22 Jul 2025
Supporting Treatment Decision-Making for Lenalidomide-Refractory Multiple Myeloma Patients Post-DRd in Italy: A Multi-Criteria Decision Framework.
In these short video series, Elena Zamagni, coauthor of the EMN Research Italy publication, shares key insights on managing…
21 Jul 2025
ICML 2025: Regional and Socioeconomic Disparities in CNS Lymphoma Outcomes
A large-scale national study of primary central nervous system lymphoma (PCNSL) in England has revealed stark differences in incidence and survival based on geography, age, and deprivation…
20 Jul 2025
ICML 2025: Bridging Radiotherapy May Reduce CAR-T-Related Toxicity
Bridging radiotherapy (BRT) before CAR-T cell therapy may help reduce severe treatment-related toxicities in patients with B-cell lymphoma…
5
Mins
17 Jul 2025
EHA 2025 Interview: Konstanze Döhner
My top priorities as EHA President align closely with the association’s strategic roadmap, which we have developed and begun to implement…
4
Mins
17 Jul 2025
New Horizons in Chronic Lymphocytic Leukaemia : An Interview with Lydia Scarfò
This year, the EHA Congress provided us with long-term follow-up of some very interesting study, including the GAIA/CLL13 trial…
17 Jul 2025
Physical Function Scores Help Predict Outcomes in Multiple Myeloma Treatment
A new study finds that how patients feel and function before starting treatment can help predict how well they’ll respond to multiple myeloma therapies.
16 Jul 2025
New Genetic Score May Guide Leukaemia Treatment
A large new study has confirmed the clinical relevance of a pharmacogenomic score that could help tailor leukaemia treatment and address persistent racial disparities in outcomes.
Loading posts...
« Previous
1
…
7
8
9
10
11
…
95
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View